Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells
Open Access
- 1 August 2010
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 285 (35), 27429-27439
- https://doi.org/10.1074/jbc.m110.142752
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cellsEndocrine-Related Cancer, 2010
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF ExpressionCell, 2010
- Inflammation and Cancer: IL-6 and STAT3 Complete the LinkCancer Cell, 2009
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated CancerCancer Cell, 2009
- Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor MicroenvironmentCancer Cell, 2009
- IL-6 involvement in epithelial cancersJCI Insight, 2007
- IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary glandJCI Insight, 2007
- Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomasJCI Insight, 2007
- Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironmentNature Reviews Immunology, 2007
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002